Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

M Gail Farfel


  • Director at Avrobio Inc. (AVRO), 2020-10-21
  • Evp/chief Development Officer at Zogenix Inc. (ZGNX), 2020-06-30
  • Director at Durect Corp (DRRX), 2020-06-19
  • Chief Clinical Dev & Reg Offic at Marinus Pharmaceuticals Inc (MRNS), 2015-04-23
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ZGNX $28.21 2,573 Officer 5,048 2020-05-12 Filing
ZGNX $52.00 3,446 Officer 4,891 2019-08-22 Filing
ZGNX $43.74 1,961 Officer 7,143 2018-10-04 Filing
ZGNX $43.11 2,900 Officer 9,104 2018-10-04 Filing
ZGNX $42.92 2,100 Officer 12,004 2018-10-04 Filing